Kadcyla

ado-trastuzumab emtansine · Genentech

Drug timelines are a Plus or Pro feature.

47 regulatory and trial events tracked for Kadcyla, covering 2013-02-22 to 2026-06-16. Get the full timeline:

Most recent: EMA Authorised: Kadcyla (trastuzumab emtansine) — Roche Registration GmbH